By Aaron Vehling ( December 8, 2014, 2:31 PM EST) -- The U.S. Supreme Court on Monday declined to consider Braintree Laboratories Inc.'s challenge to the Federal Circuit's standard for reviewing a district court's factual findings for claim construction, a petition that hinged on a question the justices are already considering in Teva Pharmaceuticals USA v. Sandoz Inc....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.